- PCSK9 Inhibition could be Effective for Acute Myocardial Infarction
Current Medicinal Chemistry · 2021
- Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Clinical Therapeutics · 2021
- Effects of atorvastatin doses on serum level of procalcitonin and predictors for major adverse cardiovascular events in patients with acute myocardial infarction: a pilot study and post hoc analysis
Coronary Artery Disease · 2021
- Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
Evidence-based Complementary and Alternative Medicine · 2021
- Elderly patient with atrial fibrillation and coronary risks
Aterotromboz = Atherothrombosis · 2021
- The risk of bleeding minimization with direct oral anticoagulants
Aterotromboz = Atherothrombosis · 2021
- Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA))
Aterotromboz = Atherothrombosis · 2021
- Possibilities of the efficiency and safety control of rivaroxaban application in patients with atrial fibrillation
Bulletin of the Russian Military Medical Academy · 2021
- Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
International Journal of Molecular Sciences · 2021
- Long-Term Incidence of Stroke and Dementia in ASCOT
Stroke · 2021
- Colchicine-induced rhabdomyolysis: a review of 83 cases
BMJ Case Reports · 2021
- Lipid-Lowering Therapy and Hemorrhagic Stroke Risk
Stroke · 2021
- Evaluation of efficacy and safety of combined rosuvastatin and atorvastatin in treating with coronary heart disease
Medicine · 2021
- Antithrombotic therapy in multimorbid patients with atrial fibrillation from standpoint of clinical recommendations of Ministry of Health of Russian Federation (2020). Effectiveness and safety of apixaban in patients with atrial fibrillation and concomitant diseases
Medical alphabet · 2021
- Safety and efficacy of rivaroxaban compared to standard anticoagulant therapy in the treatment of deep vein thrombosis in Indian population
International Surgery Journal · 2021
- Benefits and Harms of Low-Dose Rivaroxaban in Asian Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-World Studies
Frontiers in Pharmacology · 2021
- Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects ― A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial ―
Circulation Journal · 2021
- Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Cochrane Database of Systematic Reviews · 2021
- Evaluation of the effect of apixaban using a viscoelastic coagulation assay with Russell’s viper venom reagent
JA Clinical Reports · 2021
- Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
Pharmacology Research & Perspectives · 2021
- Combination of Static Echocardiographic Indices for the Prediction of Fluid Responsiveness in Patients Undergoing Coronary Surgery: A Pilot Study
Journal of Clinical Medicine · 2021
- Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus
Cardiovascular Diabetology · 2021
- Atorvastatin reverses high cholesterol‐induced cardiac remodelling and regulates mitochondrial quality‐control in a cholesterol‐independent manner: An experimental study
Clinical and Experimental Pharmacology and Physiology · 2021
- Antithrombotic Management and Long-Term Outcomes of Patients with Atrial Fibrillation. Insights from CRAFT Trial
Journal of Clinical Medicine · 2021
- Safety and Efficacy of Apixaban versus warfarin in patients with atrial fibrillation or Venous Thromboembolism and End-Stage renal disease on hemodialysis: A systematic review and meta-analysis
Indian Pacing and Electrophysiology Journal · 2021
- Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial
Trials · 2021
- Statin-Induced Triad of Autoimmune Myocarditis, Myositis, and Transaminitis
Case Reports in Cardiology · 2021
- Edoxaban Dosing Time Affects Blood Coagulation Inhibition in Rats
TH Open · 2021
- Combined application of rapamycin and atorvastatin improves lipid metabolism in apolipoprotein E-deficient mice with chronic kidney disease
BMB Reports · 2021
- Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
Journal of Personalized Medicine · 2021
- Improvement of Platelet Respiration by Cell–Permeable Succinate in Diabetic Patients Treated with Statins
Life · 2021
- Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting
Acta Diabetologica · 2021
- Management of the Gastrointestinal System Bleeding Caused by Direct-Acting Oral Anticoagulants
Journal of Experimental and Clinical Medicine · 2021
- Aortic valvular stenosis: Novel therapeutic strategies
European Journal of Clinical Investigation · 2021
- The Pharmacology, Efficacy, and Safety of Rivaroxaban in Renally Impaired Patient Populations
The Journal of Clinical Pharmacology · 2021
- Pharmacogenomics of statins and familial hypercholesterolemia
Current Opinion in Lipidology · 2021
- Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis
Frontiers in Pharmacology · 2021
- Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program
Journal of Clinical Medicine · 2021
- A narrative review of low-dose rivaroxaban in patients with atherothrombotic cardiovascular disease: vascular protection beyond anticoagulation
Cardiovascular Diagnosis and Therapy · 2021
- The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention
International Journal of ADVANCED AND APPLIED SCIENCES · 2021
- Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? – A systematic review and network meta-analysis
European Journal of Gastroenterology & Hepatology · 2021
- Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
Cardiovascular Research · 2021
- Comparison of Combined/Carvedilol Moderate Dose Atorvastatin to Single High Dose Atorvastatin for the Prevention of Contrast-Induced Nephropathy after Cardiac Catheterization
Bulletin of Faculty of Pharmacy Cairo University · 2021
- Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia
Biomedicine & Pharmacotherapy · 2021
- Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
Heart International · 2021
- Older Familial Hypercholesterolemia Patients with COVID-19
Gerontology · 2021
- The effect of selected drugs on the mitigation of myocardial injury caused by gamma radiation
Canadian Journal of Physiology and Pharmacology · 2021
- Chromogenic anti-Xa test: the ratio between heparin activity units and concentration of apixaban and rivaroxaban
Aterotromboz = Atherothrombosis · 2020
- Lipid Management in Patients Presenting With Acute Coronary Syndromes: A Review
Journal of the American Heart Association · 2020
- Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
Basic Research in Cardiology · 2020